The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells
Molecular Therapy2016Vol. 24(3), pp. 645–654
Citations Over TimeTop 1% of 2016 papers
Related Papers
- → CRISPR-Cas type I-A Cascade complex couples viral infection surveillance to host transcriptional regulation in the dependence of Csa3b(2016)71 cited
- → Employing pH-responsive RNA triplex to control CRISPR/Cas9-mediated gene manipulation in mammalian cells(2023)4 cited
- → Investigation of Conformational Dynamics Involved in Genome Editing Events by CRISPR-Cpf1(2019)